Kunshan Dongwei Technology Co.,Ltd. (SWX:KUDO)
17.80
0.00 (0.00%)
At close: Jul 31, 2025
Aerovate Therapeutics Revenue
Kunshan Dongwei Technology had revenue of 211.45M CNY in the quarter ending March 31, 2025, with 7.08% growth. This brings the company's revenue in the last twelve months to 763.98M, down -12.42% year-over-year. In the year 2024, Kunshan Dongwei Technology had annual revenue of 750.00M, down -17.51%.
Revenue (ttm)
763.98M CNY
Revenue Growth
-12.42%
P/S Ratio
16.55
Revenue / Employee
548.05K CNY
Employees
1,394
Market Cap
1.54B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 750.00M | -159.23M | -17.51% |
Dec 31, 2023 | 909.23M | -102.50M | -10.13% |
Dec 31, 2022 | 1.01B | 207.10M | 25.74% |
Dec 31, 2021 | 804.63M | 250.14M | 45.11% |
Dec 31, 2020 | 554.49M | 112.89M | 25.56% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 63.49B |
Nestlé | 90.90B |
Novartis AG | 43.89B |
ABB Ltd | 26.70B |
UBS Group AG | 38.17B |
Zurich Insurance Group AG | 62.27B |
Compagnie Financière Richemont | 20.44B |
Swiss Re AG | 38.75B |